Adaptive Biotechnologies ADPT Revenue Interest Purchase Agreement Interest
Revenue Interest Purchase Agreement Interest at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept adpt:RevenueInterestPurchaseAgreementInterest.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's revenue interest purchase agreement interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's revenue interest purchase agreement interest?
- Adaptive Biotechnologies (ADPT) reported revenue interest purchase agreement interest of $655K in Q1 2026.
- How has Adaptive Biotechnologies's revenue interest purchase agreement interest changed year-over-year?
- Adaptive Biotechnologies's revenue interest purchase agreement interest increased by 331.4% year-over-year, from -$283K to $655K.
- What does revenue interest purchase agreement interest mean?
- This represents the interest expense or related financial costs associated with revenue interest purchase agreements, often structured as royalty financing or similar arrangements. It reflects the cost of capital associated with monetizing future revenue streams. Investors monitor this to understand the impact of alternative financing structures on cash flow and long-term profitability.